LEMBOREXANT vs LENIOLISIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LEMBOREXANT vs LENIOLISIB: Safety Overview
| Metric | LEMBOREXANT | LENIOLISIB |
|---|---|---|
| Total FAERS Reports | 989 | 570 |
| Deaths Reported | 44 | 6 |
| Death Rate | 4.4% | 1.1% |
| Hospitalizations | 278 | 54 |
| Average Patient Age | 58.9 yrs | 19.4 yrs |
| % Female Patients | 63.4% | 27.3% |
| FDA Approval Date | Apr 7, 2020 | Mar 24, 2023 |
| Manufacturer | Eisai Inc. | Pharming Healthcare Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |